David L. Musso

442 citations

22 papers · 330 indexed · h-index 11

Co-authors: James L. Kelley Francis E. Soroko Nariman B. Mehta Barrett R. Cooper G. Faye Orr Greg C. Rigdon Felicia R. Cochran Darryl McDougald
Topics: Chemical Synthesis and Analysis (6 papers)Asymmetric Synthesis and Catalysis (5 papers)Coordination Chemistry and Organometallics (4 papers)
Cited by: Organic Chemistry Toxicology Immunology and Allergy
Journals: PLoS ONE Journal of Medicinal Chemistry Journal of Pharmaceutical Sciences
Partner nations: United States

In The Last Decade

David L. Musso

21 papers receiving 315 citations

Peers

Countries citing papers authored by David L. Musso

Since Specialization

Citations

This map shows the geographic impact of David L. Musso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Musso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Musso more than expected).

Fields of papers citing papers by David L. Musso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Musso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Musso. The network helps show where David L. Musso may publish in the future.

Co-authorship network of co-authors of David L. Musso

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Musso. A scholar is included among the top collaborators of David L. Musso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Musso. David L. Musso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of small molecule antagonists of sonic hedgehog/heparin binding with activity in hedgehog functional assays 2024 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·(unknown),Michael Tarpley,(unknown),(unknown),(unknown),(unknown),Mark Hughes,(unknown),(unknown),David L. Musso,Weifan Zheng,Kevin P. Williams	1
2	N-substituted phenylbenzamides of the niclosamide chemotype attenuate obesity related changes in high fat diet fed mice 2018 ·PLoS ONE ·(unknown),Sarah A. Compton,David L. Musso,Christopher P. Laudeman,(unknown),Na Yi,(unknown),Lawrence J. Forsberg,Jay E. Brenman,Jonathan Z. Sexton	13
3	Discovery of small molecule agonists for the bombesin receptor subtype 3 (BRS-3) based on an omeprazole lead 2008 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),Alejandro J. Daniels,David N. Deaton,Aaron S. Goetz,Christopher P. Laudeman,(unknown),David L. Musso,(unknown),Jerzy R. Szewczyk,Cunyu Zhang	10
4	Synthesis of novel anilinoquinolines as c-fms inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·Terrence L. Smalley,Stanley D. Chamberlain,Wendy Y. Mills,David L. Musso,(unknown),John A. Ray,Vicente Sámano,Lloyd Frick	11
5	Substrate Specificity and Novel Selective Inhibitors of TNF-α Converting Enzyme (TACE) from Two-Dimensional Substrate Mapping 2005 ·Combinatorial Chemistry & High Throughput Screening ·Millard H. Lambert,(unknown),Theresa Seaton,Daniel B. Kassel,(unknown),(unknown),(unknown),Janet Warner,(unknown),(unknown),David J. Cowan,Michael D. Gaul,Kimberly G. Petrov,Michael H. Rabinowitz,Robert W. Wiethe,J. David Becherer,Darryl McDougald,David L. Musso,Robert Andrews,Marcia L. Moss	21
6	Novel 3-phenylprop-2-ynylamines as inhibitors of mammalian squalene epoxidaseElectronic supplementary information (ESI) available: Proton NMR spectra for the intermediate piperidines 56–60 and acetylenes 63-81 and 85,86. See http://www.rsc.org/suppdata/ob/b2/b209165h/ 2003 ·Organic & Biomolecular Chemistry ·David L. Musso,(unknown),James L. Kelley,(unknown),Grace Chen	27
7	Preface 2003 ·Current Topics in Medicinal Chemistry ·David L. Musso	0
8	Indanylidenes. 1. Design and Synthesis of (E)-2-(4,6-Difluoro-1-indanylidene)acetamide, a Potent, Centrally Acting Muscle Relaxant with Antiinflammatory and Analgesic Activity 2002 ·Journal of Medicinal Chemistry ·David L. Musso,Felicia R. Cochran,James L. Kelley,Ed W. McLean,(unknown),Greg C. Rigdon,G. Faye Orr,(unknown),Barrett R. Cooper,Virgil L. Styles,James B. Thompson,William R. Hall	55
9	Indanylidenes. 2. Design and Synthesis of (E)-2-(4-Chloro-6-fluoro-1-indanylidene)-N-methylacetamide, a Potent Antiinflammatory and Analgesic Agent without Centrally Acting Muscle Relaxant Activity 2002 ·Journal of Medicinal Chemistry ·David L. Musso,G. Faye Orr,Felicia R. Cochran,James L. Kelley,(unknown),Greg C. Rigdon,Barrett R. Cooper,Michael L. Jones	10
10	Design of Selective and Soluble Inhibitors of Tumor Necrosis Factor-α Converting Enzyme (TACE) 2001 ·Journal of Medicinal Chemistry ·Michael H. Rabinowitz,Robert Andrews,J. David Becherer,D. Mark Bickett,(unknown),James G. Conway,David J. Cowan,Micheal D. Gaul,(unknown),Millard H. Lambert,M. Anthony Leesnitzer,Darryl McDougald,Marcia L. Moss,David L. Musso,Michèle Rizzolio	57
11	Inhibition of Uridine Phosphorylase. Synthesis and Structure−Activity Relationships of Aryl-Substituted 1-((2-Hydroxyethoxy)methyl)-5-(3-phenoxybenzyl)uracil 1997 ·Journal of Medicinal Chemistry ·G. Faye Orr,David L. Musso,James L. Kelley,S S Joyner,Stephen T. Davis,David P. Baccanari	7
12	Synthesis and evaluation of the anticonvulsant activity of a series of 2-amino-1-phenyl-1-propanols derived from the metabolites of the antidepressant bupropion 1997 ·Bioorganic & Medicinal Chemistry Letters ·David L. Musso,Nariman B. Mehta,Francis E. Soroko	16
13	Synthesis, stereochemistry and anti‐tetrabenazine activity of bicyclo analogues of 2‐phenylmorpholines 1997 ·Journal of Heterocyclic Chemistry ·(unknown),David L. Musso,(unknown),James L. Kelley,Francis E. Soroko,(unknown)	7
14	(2S,3S,5R)-2-(3,5-Difluorophenyl)-3,5- dimethyl-2-morpholinol: A Novel Antidepressant Agent and Selective Inhibitor of Norepinephrine Uptake 1996 ·Journal of Medicinal Chemistry ·James L. Kelley,David L. Musso,(unknown),Francis E. Soroko,Barrett R. Cooper	30
15	Synthesis and anti‐tetrabenazine activity of c‐3 analogues of dimethyl‐2‐phenylmorpholines 1996 ·Journal of Heterocyclic Chemistry ·(unknown),David L. Musso,James L. Kelley,Francis E. Soroko,(unknown)	8
16	Inhibition of uridine phosphorylase: synthesis and structure-activity relationships of aryl-substituted 5-benzyluracils and 1-[(2-hydroxyethoxy)methyl]-5-benzyluracils. 1995 ·Journal of Medicinal Chemistry ·G. Faye Orr,David L. Musso,(unknown),James L. Kelley,S S Joyner,Stephen T. Davis,David P. Baccanari	8
17	Design and synthesis of a chiral hapten for a radioimmunoassay of the antidepressant (2S, 3S, 5R)-2-(3,5-difluorophenyl)-3,5-dimethyl-2-morpholinol hydrochloride 1995 ·Tetrahedron Asymmetry ·David L. Musso,James L. Kelley	2
18	Synthesis and evaluation of the antidepressant activity of the enantiomers of bupropion 1993 ·Chirality ·David L. Musso,Nariman B. Mehta,Francis E. Soroko,Robert M. Ferris,Elizabeth B. Hollingsworth,(unknown)	32
19	Design and Synthesis of a Hapten for the Radioimmunoassay of Bupropion 1986 ·Journal of Pharmaceutical Sciences ·Nariman B. Mehta,David L. Musso	3
20	Separations of Threo-Erythro Aminoalcohols by Preparative HPLC 1981 ·Journal of Liquid Chromatography ·David L. Musso,Nariman B. Mehta	5

About David L. Musso

David L. Musso is a scholar working on Pharmaceutical Science, Organic Chemistry and Molecular Biology, having authored 22 papers that have together received 330 indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (6 papers), Asymmetric Synthesis and Catalysis (5 papers) and Coordination Chemistry and Organometallics (4 papers). The work is most often cited by research in Organic Chemistry (145 citations), Toxicology (9 citations) and Immunology and Allergy (15 citations). David L. Musso has collaborated with scholars based in United States. Frequent co-authors include James L. Kelley, Francis E. Soroko, Nariman B. Mehta, Barrett R. Cooper, G. Faye Orr, Greg C. Rigdon, Felicia R. Cochran, Darryl McDougald, Marcia L. Moss and Robert M. Ferris. Their work appears in journals such as PLoS ONE, Journal of Medicinal Chemistry and Journal of Pharmaceutical Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact